Proton Therapy in the Treatment of Anal Cancer in Pelvic Kidney Transplant Recipients: A Case Series

被引:6
|
作者
Buchberger, David [1 ]
Kreinbrink, Paul [1 ]
Kharofa, Jordan [1 ]
机构
[1] Univ Cincinnati, Dept Radiat Oncol, Med Ctr, 234 Goodman St,ML 0757, Cincinnati, OH 45267 USA
关键词
intensity-modulated proton therapy; anal cancer; anal neoplasia; kidney transplant; pelvic kidney; RENAL-TRANSPLANTATION; RANDOMIZED-TRIAL; CARCINOMA; ORGAN; CHEMORADIATION; RADIOTHERAPY; MITOMYCIN; RISK; 5-FLUOROURACIL; CHEMOTHERAPY;
D O I
10.14338/IJPT-19-00067.1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The incidence of anal cancer in patients with kidney transplants has increased. The definitive treatment for anal cancer is chemotherapy and intensity-modulated radiation therapy. In kidney transplant recipients, sparing the pelvic kidney in the process of delivering radiation to the anus can be challenging. Intensity-modulated proton therapy (IMPT) has been proposed as an alternative to intensity-modulated radiation therapy for the treatment of anal cancer in this population, given its increased ability to spare organs-at-risk. Case Series: We present 4 cases of patients with transplanted pelvic kidneys who subsequently developed anal cancer and were treated with IMPT from 2017 to 2019. Conclusion: Use of IMPT appears to be an acceptable option for the treatment of anal cancer in patients with a pelvic kidney.
引用
收藏
页码:28 / 34
页数:7
相关论文
共 50 条
  • [1] Scanning proton beam therapy reduces normal tissue exposure in pelvic radiotherapy for anal cancer
    Anand, Aman
    Bues, Martin
    Rule, William G.
    Keole, Sameer R.
    Beltran, Chris J.
    Yin, Jun
    Haddock, Michael G.
    Hallemeier, Christopher L.
    Miller, Robert C.
    Ashman, Jonathan B.
    RADIOTHERAPY AND ONCOLOGY, 2015, 117 (03) : 505 - 508
  • [2] Tuberculosis in kidney transplant recipients:A case series
    Manish Anand
    Ekta Nayyar
    Beatrice Concepcion
    Megha Salani
    Heidi Schaefer
    World Journal of Transplantation, 2017, (03) : 213 - 221
  • [3] Abatacept Rescue Therapy in Kidney Transplant Recipients: A Case Series of Five Patients
    Uro-Coste, Charlotte
    Atenza, Alba
    Heng, Anne-Elisabeth
    Rouzaire, Paul-Olivier
    Garrouste, Cyril
    TRANSPLANT INTERNATIONAL, 2022, 35
  • [4] Cancer survival in kidney transplant recipients in Ireland
    Murray, Susan L.
    O'Leary, Eamonn
    De Bhailis, Aine M.
    Deady, Sandra
    Daly, Fergus E.
    O'Kelly, Patrick
    Williams, Yvonne
    O'Neill, James P.
    Sexton, Donal J.
    Conlon, Peter J.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 (10) : 1802 - 1810
  • [5] Role of pelvic chemoradiation therapy in patients with initially metastatic anal canal cancer: A National Cancer Database review
    Abdelazim, Yasser A.
    Rushing, Christel N.
    Palta, Manisha
    Willett, Christopher G.
    Czito, Brian G.
    CANCER, 2019, 125 (12) : 2115 - 2122
  • [6] Cancer Screening and Cancer Treatment in Kidney Transplant Recipients
    Vieira, Miguel Bigotte
    Arai, Hiroyuki
    Nicolau, Carla
    Murakami, Naoka
    KIDNEY360, 2024, 5 (10): : 1569 - 1583
  • [7] Cardiovascular Complications in Kidney Transplant Recipients with COVID-19: A Case Series
    Patil, Ankita
    Rao, Nikhil
    Kumar, Kruteesh
    Modi, Tulsi
    Gandhi, Chintan
    Deb, Satarupa
    Bose, Sreyashi
    Saxena, Nikhil
    Katyal, Abhinav
    Thakare, Sayali
    Pajai, Atim E.
    Bajpai, Divya
    Jamale, Tukaram
    INDIAN JOURNAL OF NEPHROLOGY, 2022, 32 (05) : 506 - 511
  • [8] Multimodality treatment of oligometastatic anal squamous cell carcinoma: A case series and literature review
    Sclafani, Francesco
    Hesselberg, Gina
    Thompson, Stephen R.
    Truskett, Philip
    Haghighi, Koroush
    Rao, Sheela
    Goldstein, David
    JOURNAL OF SURGICAL ONCOLOGY, 2019, 119 (04) : 489 - 496
  • [9] Pencil Beam Scanning (PBS) Intensity-Modulated Proton Therapy (IMPT) Chemoradiotherapy for Anal Canal Cancer-Single Institution Experience
    Vitek, Pavel
    Kubes, Jiri
    Vondracek, Vladimir
    Andrlik, Michal
    Navratil, Matej
    Zapletal, Radek
    Haas, Alexandra
    Dedeckova, Katerina
    Ondrova, Barbora
    Grebenyuk, Alexander
    Rosina, Jozef
    CANCERS, 2022, 14 (01)
  • [10] Outcomes of kidney transplant recipients with ESKD due to plasma cell dyscrasia: A case series
    Dinh, Alex R.
    Wong, Sandy W.
    Martin, Thomas G.
    Wolf, Jeffrey L.
    Webber, Allison B.
    CLINICAL TRANSPLANTATION, 2022, 36 (03)